Capecitabine dominant over fluorouracil/levofolinate in Japan

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.586, 2009-01, pp. : 6-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost-Effectiveness Analysis of Capecitabine Compared with Bolus 5-Fluorouracil/l-Leucovorin for the Adjuvant Treatment of Colon Cancer in Japan

By Shiroiwa Takeru

PharmacoEconomics, Vol. 27, Iss. 7, 2009-07 ,pp. : 597-608

Adis International

Access to resources Recommend Favorite

Calcium levofolinate/fluorouracil/oxaliplatin: Interstitial lung disease in an elderly patient: case report

Reactions Weekly, Vol. 1, Iss. 1354, 2011-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite

Combination treatment with gemcitabine, oxaliplatin, fluorouracil and calcium levofolinate in patients with advanced colorectal cancer has high antitumour activity

Inpharma, Vol. 1, Iss. 1445, 2004-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Capecitabine equivalent to IV fluorouracil in colorectal cancer

Inpharma, Vol. 1, Iss. 1316, 2001-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Capecitabine dominant in Dukes' C colon cancer

Inpharma, Vol. 1, Iss. 1658, 2008-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite